Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast
Author(s) -
Sebastian Treusch,
Shusei Hamamichi,
Jessica L. Goodman,
Kent Matlack,
Chee Yeun Chung,
Valeriya Baru,
Joshua M. Shulman,
Antonio Parrado,
Brooke J. Bevis,
Julie S. Valastyan,
Haesun Han,
Malin LindhagenPersson,
Eric M. Reiman,
Denis A. Evans,
David A. Bennett,
Anders Olofsson,
Philip L. DeJager,
Rudolph E. Tanzi,
Kim A. Caldwell,
Guy A. Caldwell,
Susan Lindquist
Publication year - 2011
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.1213210
Subject(s) - yeast , endocytic cycle , toxicity , organism , disease , amyloid (mycology) , model organism , biology , alzheimer's disease , medicine , biochemistry , genetics , gene , cell , pathology , endocytosis , botany
Aβ (beta-amyloid peptide) is an important contributor to Alzheimer's disease (AD). We modeled Aβ toxicity in yeast by directing the peptide to the secretory pathway. A genome-wide screen for toxicity modifiers identified the yeast homolog of phosphatidylinositol binding clathrin assembly protein (PICALM) and other endocytic factors connected to AD whose relationship to Aβ was previously unknown. The factors identified in yeast modified Aβ toxicity in glutamatergic neurons of Caenorhabditis elegans and in primary rat cortical neurons. In yeast, Aβ impaired the endocytic trafficking of a plasma membrane receptor, which was ameliorated by endocytic pathway factors identified in the yeast screen. Thus, links between Aβ, endocytosis, and human AD risk factors can be ascertained with yeast as a model system.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom